Physician profile
Eileen Walsh
NPI 1114097433
$1,382.35
in general payments reported to CMS, 2019-2025
13 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $380 · 2023: $370 · 2024: $311 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $270.09 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Gilead Sciences, INC. | $125.37 | 2024 | Veklury |
| Harmony Biosciences LLC | $125.01 | 2024 | |
| Viiv Healthcare Company | $125.00 | 2023 | Apretude |
| Idorsia Pharmaceuticals US INC | $124.47 | 2022 | |
| Viatris Specialty LLC | $117.98 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $112.74 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $105.10 | 2021 | |
| Mylan Specialty L.P. | $101.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $97.85 | 2021 | |
| Sanofi Pasteur INC. | $35.08 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $21.36 | 2024 | |
| Janssen Biotech, INC. | $20.69 | 2024 | Tremfya, Simponi Aria, Simponi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.